Member Info for BuenaVista

You have to click on AVA028 on the Pipeline page: https://avacta.com/therapeutics/pipeline/

"... A number of potential ImmunoCytokines are under development."

Fact, fact. 😂😂😂

Plain to see. Now go away.

Oh dear. TW sending them into battle now only armed with a rolled up soggy newspaper.

193,037 @ 159.451 (£307.8k) @ 09:37

Recorded on LSE as a sale (spread 159/161) but whether a sale or a buy, big money is being moved around.

Oh yes Muck, I'm sure the data is good if it is being presented at a major conference alongside what we know to be good preclinical pre|CISION data. Looking forward to the explainer.

A question for the those experienced in the dark arts of this market: it has been suggested that a buy order is being filled as at least part of the reason for the high volume this week. Is the evidence for this strong? There seems to be a ceiling around 163 - is that likely to be the maximum that the buyer wants to pay?

Thanks gmcc. Very interesting, but I'm not sure I'm any the wiser - and that's from reading just the Introduction and Summary!

@Moneysponge, some points of clarification so that you don't repeat untruths.

Firstly, it is Affimers (no 'r' and capitalised as it is a registered name, and should strictly be written as Affimer® when referring specifically to the tech platform. (Registered name: the official or trademark name of something such as a product or company.) Also, something I've noticed: it is Alastair, not Alistair.

But most importantly for other investors' information, there is no way in hell we will be "selling £5bn+ per year in two years time." The pivotal Phase 2 study will only be for one or two STS sub-types. Consequently, approval would only definitely be given for use as first line standard of care for those subtypes. And sales would not rocket up to £5bn+ so soon anyway as a lot of things need to be organised and put in place - manufacturing, distribution, marketting, registration in other regulatory authority territories, and bureaucracy, bureaucracy, bureaucracy (c.f. Alastair's referrence to how slow the MHRA is). Finally, Avacta will need to contract most of this out so not all sales revenue will come to Avacta.

👍 Hope it continues that way.

Pretty sure that Victoria, or Fiona, will the talking to the poster with Fiona, and Victoria and the guy who hands round the coffees and biscuits, available for discussions after the details have been gone through.

"The posters will be available to view following the conference here: https://avacta.com/about/scientific-resources/"

Read that how you will.😉

Maybe you could do that in 0's and 1's for HurstBot...

Are you saying Big Pharma is acting as a cartel? How far down the MCap does this cartel extend?

Have the MMs just upped the prices just ahead of the Wall St open? HurstBot!???

"The ones that only tweet buys and never sells"

Now... which twat does that remind me of... Sorry, it was such a nonentity I've forgotten which of the TW cultists it was. Anyone remember who the idiot with the 'McNulty only tweets buys and never sells' line was?

Good to see you've still got your traders hat on Monkeysponge. However, yes, the first poster presentation (tomorrow) is the Affimer one which will be totally new to everyone so could have a big impact. The AVA3996 poster on Saturday is old hat - data was presented at (help me out HurstBot...) ASCO(?) in April (definitely April, I think) and is just another pre|CISION prodrug.🥱😉😂

"JAdams reported for spamming. Suggest everyone does the same."

And as if by magic the self-publicist's post disappears.

Congratulations. You've all done very well (for those that remember).

Whooooossshhh!!!!

What is it telling me Rambo?

JAdams reported for spamming. Suggest everyone does the same.